Enrifol 2mg Tablet contains Estradiol, a potent estrogen hormone used primarily in hormone replacement therapy (HRT) for managing symptoms associated with menopause, such as vasomotor disturbances (hot flashes), vaginal atrophy, and osteoporosis prevention in postmenopausal women. Estradiol is a bioidentical form of estrogen that helps restore hormonal balance by supplementing diminished endogenous estrogen levels. Enrifol is indicated for the treatment of moderate to severe vasomotor symptoms, prevention of postmenopausal osteoporosis in women at high risk of fracture, and management of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure. The tablet should be administered orally as prescribed by a healthcare professional, with dosage individualized based on patient response and therapeutic goals. Contraindications include known or suspected estrogen-dependent neoplasms, undiagnosed abnormal genital bleeding, active or history of thromboembolic disorders, and liver dysfunction. Caution is advised in patients with cardiovascular disease, hypertension, or a history of hormone-sensitive cancers. Common adverse effects may include nausea, headache, breast tenderness, and breakthrough bleeding. Regular monitoring and follow-up are essential to evaluate therapeutic efficacy and detect potential adverse reactions. Enrifol 2mg Tablet should be used under strict medical supervision to ensure safe and effective hormone replacement therapy.